(“MediBeacon”), a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, and an equity method investment of INNOVATE, announced ...
INNOVATE Corp. (NYSE: VATE) shares began Tuesday in the green. The New York-based company announced that MediBeacon Inc., a medical technology company specializing in the advancement of fluorescent ...
GlobalData on MSN
MediBeacon secures CE mark certification for TGFR monitor and sensor
Lumitrace is currently approved in China and the US, with submission to EU regulatory authorities pending.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results